Bayer AG To Produce CureVac COVID-19 Vaccine

WUPPERTAL, GERMANY - FEBRUARY 15: (AUDIO OMITTED) Cars drive past the Bayer AG Biotechnikum facility, where the CureVac CVnCoV COVID-19 vaccine will be produced, on February 15, 2021 in Wuppertal, Germany. EMA, the European Medicines Agency, recently began the expedited approval process for the CureVac vaccine. (AUDIO OMITTED) (Footage by Andreas Rentz/Getty Images)
WUPPERTAL, GERMANY - FEBRUARY 15: (AUDIO OMITTED) Cars drive past the Bayer AG Biotechnikum facility, where the CureVac CVnCoV COVID-19 vaccine will be produced, on February 15, 2021 in Wuppertal, Germany. EMA, the European Medicines Agency, recently began the expedited approval process for the CureVac vaccine. (AUDIO OMITTED) (Footage by Andreas Rentz/Getty Images)
PURCHASE A LICENCE

Get personalised pricing by telling us when, where, and how you want to use this asset.

DETAILS

Editorial #:
1302304160
Collection:
Getty Images News Video
Date created:
15 February, 2021
Upload date:
Licence type:
Rights-ready
Release info:
Not released. More information
Clip length:
00:00:15:14
Location:
Wuppertal, North Rhine-Westphalia, Germany
Mastered to:
MPEG-4 8-bit H.264 4K 4096x2160 25p
Originally shot on:
QuickTime - H.264 2160 25p
Source:
Getty Images News Video
Object name:
bayer01_4z5a8377